New Delhi: Entode Pharmaceuticals has received final approval for the drug Presvu from the Drug Controller General of India (DCGI). After this, this drug can prove to be very effective for people affected by presbyopia. This approval has been received after the prior recommendation of the Subject Expert Committee of CDSC (Central Drugs Standard Control Organization).
This medicine is very useful
The company says that Presvu is India's first drug developed to reduce dependence on reading glasses for individuals affected by presbyopia. It is a common age-related vision condition that usually affects people over 40. Presvu has also applied for a patent for invention regarding its manufacture and process. The specialty of this eye drop is that it starts showing its work within 15 minutes of entering the eyes. Its effect lasts for 6 hours. Another special thing is that if the second drop is also put within three to six hours of the first drop, then the effect lasts even longer. To buy this medicine, you will have to pay Rs 350.What is presbyopia?
Presbyopia is the medical term for your eyes losing the ability to change focus. It affects how well you can see near objects. It happens when the natural lens in your eyes becomes less flexible as you age. Presbyopia usually starts to develop around age 40 and gets worse by the mid-60s. You'll notice that reading or doing other close-up things has become harder than before. You may have to hold your book or phone at arm's length to see the words clearly. You may also have symptoms like headaches or eye irritation, fatigue.
`; articlesDiv.innerHTML += articleHTML; }); } // Initialize and render feeds fetchAndRenderFeeds();